Altria Group, Inc.

MO

US02209S1033

Altria Group, Inc. is a holding company organized around three sectors of activity: - manufacturing of tobacco products (88.9% of net sales): cigarettes (brands Marlboro, L&M, Philip Morris, Chesterfield, etc.), cigars (Black & Mild), and pipe tobacco; - manufacturing of smokeless tobacco products (6.8%): brands Copenhagen, Skoal, Red Seal, etc.; - other (0.3%). The group also owns a 10% share in Anheuser-Busch InBev.

Sector

Tobacco

Calendar

2024-07-31 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Altria Group, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

45.74 USD

Average target price

47.01 USD

Spread / Average Target

+2.78%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Cigars & Cigarette Manufacturing

	1st Jan change	Capi.
ALTRIA GROUP, INC.	+13.39%	78.56B
ITC LIMITED	-9.20%	62.68B
JAPAN TOBACCO, INC.	+21.15%	49.14B
KT&G CORPORATION	-0.69%	7B
PT HANJAYA MANDALA SAMPOERNA TBK	-22.35%	4.91B
PT GUDANG GARAM TBK	-9.72%	2.15B
BRITISH AMERICAN TOBACCO BANGLADESH COMPANY LIMITED	-37.23%	1.49B
SCANDINAVIAN TOBACCO GROUP A/S	-17.14%	1.15B
EASTERN COMPANY S.A.E	-19.24%	1.07B
KARELIA TOBACCO COMPANY INC.	-2.92%	979M

Cigars & Cigarette Manufacturing

Market Closed - Nyse Other stock markets 16:00:02 2024-06-21 EDT			5-day change	1st Jan Change
45.74 ^USD	+0.68%		+3.20%	+13.39%

06-21	Consumer Stocks Rise As Retailers Battle Inflation -- Consumer Roundup	DJ
06-21	In a first, FDA authorizes flavored vape products from Altria's NJOY for sale	RE

Consumer Stocks Rise As Retailers Battle Inflation -- Consumer Roundup	06-21	DJ
In a first, FDA authorizes flavored vape products from Altria's NJOY for sale	06-21	RE
In a first, FDA authorizes flavored e-cigarettes from Altria's NJOY for sale in the US	06-21	RE
Altria Group's NJOY Gets FDA Approval to Market 4 E-Cigarettes Products	06-21	MT
Deutsche Bank Adjusts Altria Group Price Target to $52 From $50, Maintains Buy Rating	06-21	MT
UBS Trims Price Target on Altria to $36 From $36.50, Maintains Sell Rating	06-14	MT
US FDA rescinds market denial order for Juul products	06-06	RE
Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says	05-29	RE
Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says	05-29	RE
Altria's NJOY Submits Application to FDA for Vaping Device With Access-Restriction Tech	05-20	DJ
Declaration of Voting Results by Altria Group, Inc	05-20	CI
Declaration of Voting Results by Altria Group, Inc	05-20	CI
Altria Group Maintains Quarterly Dividend at $0.98 a Share; Payable July 10 to Shareholders of Record as of June 14	05-16	MT
Altria Group, Inc. Declares Regular Quarterly Dividend, Payable on July 10, 2024	05-16	CI
Altria Group Insider Sold Shares Worth $988,360, According to a Recent SEC Filing	05-06	MT
US class action settlements flooded with fraudulent claims by scammers	05-02	RE
Jefferies Adjusts Altria Group Price Target to $48 From $47	05-01	MT
Philip Morris faces key test with US heated tobacco push	04-29	RE
Federal Government Delays Decision to Ban Menthol-Flavored Cigarettes	04-26	MT
Biden Administration Drops Plan to Ban Menthol Cigarettes	04-26	MT
Transcript : Altria Group, Inc., Q1 2024 Earnings Call, Apr 25, 2024	04-25
Altria Group Q1 Adjusted Earnings, Net Revenue Decrease	04-25	MT
Altria tops first quarter sales on higher pricing, robust demand for smokeless alternatives	04-25	RE
Earnings Flash (MO) ALTRIA GROUP Posts Q1 Revenue $5.58B, vs. Street Est of $4.73B	04-25	MT
Earnings Flash (MO) ALTRIA GROUP Posts Q1 EPS $1.15, vs. Street Est of $1.15	04-25	MT

Altria Group, Inc.

Equities

MO